TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← All Stock Lists
▌Top Stocks · WATER INFRASTRUCTURE·Updated September 26, 2026

Best Water Infrastructure Stocks for September 2026: 7 Picks

A seven-stock countdown spans regulated utilities, pumps, valves, filtration, treatment, leak detection, and digital water-management businesses.

Top Stocks · WATER INFRASTRUCTUREUpdated September 26, 2026
AOSPNRMWAXYLECL+2 locked
Last refreshed September 26, 2026·14 min read
Best Water Infrastructure Stocks for September 2026: 7 Picks

Water infrastructure remains a steady, long-duration investment theme rather than a fast-moving trade. Aging pipes, treatment plants, pumps, valves, and distribution networks require sustained replacement and modernization, while water scarcity, stricter quality standards, population growth, and data-center construction can keep spending elevated. The essential nature of water systems also creates a relatively durable demand backdrop: communities and businesses must maintain, repair, treat, and distribute water regardless of short-term economic sentiment.

The opportunity set spans several business models. Regulated utilities own and operate water networks; equipment companies supply pumps, valves, meters, tanks, heaters, and treatment systems; filtration and specialty-chemicals providers help customers meet quality and efficiency requirements; and monitoring, engineering, and service businesses support leak detection, asset management, and municipal projects. The U.S. EPA’s July 2026 push to accelerate water-infrastructure investment with states, water systems, and small communities adds to the policy support for this long-term spending cycle.

This seven-stock countdown moves from #7 to #1, combining direct exposure to water infrastructure with business quality, growth, profitability, valuation, and earnings execution. The lower-ranked names offer focused exposure through equipment or treatment products, while the companies revealed later in the countdown provide increasingly direct utility or infrastructure participation. Investors should still distinguish between regulated asset owners, industrial suppliers, and diversified water-services businesses because their sensitivity to interest rates, construction cycles, and municipal budgets differs.

Methodology brief: The screen was limited to US-listed companies with market capitalizations above $500 million and meaningful exposure to water infrastructure, including utilities, equipment, treatment, filtration, measurement, and water-management services. The ranking first emphasizes depth of exposure to the theme and then considers business fundamentals, including profitability, growth, valuation, balance-sheet indicators, composite quality grades, and earnings consistency. The list is presented in countdown order, so the best pick is reserved for #1 at the end. Figures reflect the latest available primary-source financial data and composite metrics.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

7. AOS — Smith AO Corporation

Market cap: $8.0B · Quality grade: A- · Analyst consensus: Hold (avg target $69.91)

What they do. The company manufactures residential and commercial gas and electric water heaters, boilers, heat pumps, tanks, and water-treatment products. Its brands include A. O. Smith, State, Lochinvar, Hague, Water-Right, and Aquasana, and it sells through plumbing distributors, hardware and home-center chains, dealer networks, representatives, and e-commerce. That combination gives A. O. Smith exposure to both replacement demand and new construction across residential, commercial, and institutional end markets.

Why it fits. Water heating, boilers, filtration, softening, and reverse-osmosis systems are practical components of building and water-system upgrades. The company’s commercial products serve hospitals, schools, hotels, apartments, restaurants, laundries, and other facilities, while its point-of-entry and point-of-use products address household water quality. That is meaningful theme exposure, though it is more focused on water equipment and treatment than on municipal transmission networks.

Numbers that matter. A. O. Smith reported a 38.6% gross margin, 18.93% operating margin, and 13.15% net margin, with return on equity of 27.13% and return on assets of 12.54%. Revenue declined 0.7% year over year and earnings declined 15%, indicating a softer recent operating backdrop, although next-year estimated EPS is $4.0863 versus trailing EPS of $3.59. The core valuation shows a 16.337 trailing P/E and 13.8122 forward P/E, while EBITDA was $783.7 million on revenue of $3.805 billion.

Recent momentum. The latest reported quarter, dated July 30, produced EPS of $1.03 versus a $0.96 estimate, a 7.3% beat. That helped produce a 5/7 earnings beat rate across the completed quarters in the supplied history, despite a 9.6% miss in April. Analyst sentiment is more cautious than the operating returns: the breakdown shows 1 Buy, 6 Holds, and 1 Sell, with a 3.4615 consensus score and an average target of $69.9091.

6. PNR — Pentair PLC

Market cap: $8.5B · Quality grade: A- · Analyst consensus: Buy (avg target $77.36)

What they do. Pentair provides water solutions through its Flow, Water Solutions, and Pool segments. Its products include pumps, pressure vessels, membrane bioreactors, wastewater-reuse systems, advanced membrane filtration, valves, water-treatment systems, filtration products, and point-of-entry and point-of-use equipment. The business sells across North America, Europe, Asia, Latin America, the Middle East, and Australia under a broad portfolio of established brands, giving it scale across residential, commercial, agricultural, industrial, and pool applications.

Why it fits. Pentair reaches several of the theme’s most relevant sub-segments: fluid movement, wastewater reuse, membrane filtration, water softening, commercial water management, and filtration services. Its Flow segment is particularly aligned with infrastructure modernization because pumps, valves, treatment systems, and separation equipment are needed to move and process water. The Pool segment adds diversification but also means the company is not a pure municipal-infrastructure play.

Numbers that matter. Pentair’s 41.4% gross margin, 23.44% operating margin, and 16.24% net margin compare favorably with many industrial businesses, while return on equity was 17.13% and return on assets was 8.66%. Revenue fell 17% year over year and earnings declined 11.1%, but estimated next-year EPS of $5.1686 is above trailing EPS of $3.72. The core valuation was 14.2554 times trailing earnings and 10.7296 times forward earnings, with $1.035 billion of EBITDA on $4.012 billion of revenue.

Recent momentum. Pentair’s latest reported quarter delivered EPS of $1.14 against a $1.12 estimate, a 1.8% beat. It has beaten estimates in all 7 completed quarters in the supplied earnings history, including a 4.3% beat in April and a 9.9% beat in April 2025. Analyst sentiment shows 2 Buys, 3 Holds, and 2 Sells, corresponding to a 4.0526 consensus score and an average target of $77.3571.

5. MWA — Mueller Water Products

Market cap: $3.4B · Quality grade: A · Analyst consensus: Buy (avg target $29.50)

What they do. Mueller Water Products manufactures valves, fire hydrants, pipe-repair products, meters, leak-detection systems, and pipe-condition assessment tools for municipal, residential, and non-residential markets. Its Water Flow Solutions and Water Management Solutions segments sell under brands including Mueller, Pratt, Echologics, Hersey, HYMAX, and U.S. Pipe Valve and Hydrant. The company combines physical infrastructure components with intelligent water solutions such as pressure management, network analytics, event management, and data logging.

Why it fits. Mueller is one of the most direct equipment exposures in the group because its products are used in water transmission, distribution, treatment facilities, and infrastructure repair. Valves and hydrants are basic network components, while couplings, clamps, leak detection, and condition-assessment systems address the replacement and efficiency needs created by aging pipes. Its municipal focus also connects the company directly to public water investment and compliance-related spending.

Numbers that matter. Mueller reported a 38.1% gross margin, 23.95% operating margin, and 15.02% net margin, with return on equity of 21.68% and return on assets of 10.62%. Revenue grew 4.1% year over year, while earnings growth reached 30.3%; estimated next-year EPS of $1.5868 is above trailing EPS of $1.42. Its core trailing P/E was 15.2324 and forward P/E was 13.7552, supported by $360.7 million of EBITDA on $1.479 billion of revenue.

Recent momentum. The latest quarter, reported August 5, produced EPS of $0.50 versus an estimate of $0.39, a 28.2% beat. Mueller has beaten estimates in 6 of the 7 completed quarters in the supplied history, with additional beats of 8.1% in May and 11.5% in February. The analyst breakdown contains 3 Holds and no reported Buy or Sell counts, alongside a 3.8 consensus score and an average target of $29.50.

Get AI research on any stock

Instant reports, daily intelligence, and an AI analyst in your pocket.

Get Started →

4. XYL — Xylem Inc

Market cap: $24.0B · Quality grade: B+ · Analyst consensus: Buy (avg target $153.88)

What they do. Xylem designs, manufactures, and services engineered products for utility, industrial, residential, and commercial water applications. Its portfolio includes water, wastewater, and stormwater pumps; filtration, disinfection, and biological-treatment equipment; meters, sensors, controls, software, cloud analytics, remote monitoring, and managed services. It also provides process and wastewater treatment, reverse osmosis, continuous deionization, mobile dewatering, asset management, condition assessment, and municipal services, creating a broad end-to-end water technology and service platform.

Why it fits. Xylem touches nearly every major infrastructure requirement in the theme: moving water, treating wastewater, managing stormwater, measuring usage, detecting problems, and monitoring distributed assets. Its smart meters, communication devices, analytics, and remote-monitoring tools align with the industry’s shift toward efficiency and digital asset management, while pumps and treatment systems participate in physical replacement cycles. The company’s worldwide reach and service capabilities broaden its exposure beyond individual municipal projects.

Numbers that matter. Xylem generated a 39.2% gross margin, 17% operating margin, and 11.15% net margin, with return on equity of 9.18% and return on assets of 5.11%. Revenue growth was 1.5% year over year, while earnings growth was 19.5%; estimated next-year EPS of $6.2455 is well above trailing EPS of $3.97. The valuation was richer than the smaller equipment names, at 25.8589 times trailing earnings and 17.3913 times forward earnings, with EBITDA of $1.978 billion on revenue of $9.126 billion.

Recent momentum. Xylem’s latest reported quarter produced EPS of $1.46 versus an estimate of $1.34, a 9.0% beat. The company has beaten estimates in all 7 completed quarters in the supplied history, including an 11.4% beat in October 2025. Analysts reported 5 Buys and 8 Holds with no Sell count, a 4.0455 consensus score, and an average target of $153.875.

3. ECL — Ecolab Inc

Market cap: $77.2B · Quality grade: B · Analyst consensus: Buy (avg target $324.95)

What they do. Ecolab provides water-treatment, cleaning, sanitizing, hygiene, and infection-prevention solutions through its Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences segments. Its water business serves manufacturing, food and beverage, transportation, chemicals, metals and mining, power generation, refining, petrochemicals, and pulp and paper. The company sells through field sales, corporate-account personnel, distributors, and dealers, combining products with recurring service relationships across industrial and institutional customers.

Why it fits. Ecolab provides the treatment chemistry, process expertise, monitoring, and service support that help industrial customers conserve water, control contamination, and meet operating and quality requirements. Its exposure is less about owning pipes or selling large municipal equipment and more about recurring water-efficiency and treatment spending inside facilities. That makes Ecolab a differentiated way to participate in water scarcity, reuse, compliance, and industrial process optimization.

Numbers that matter. Ecolab’s 44.2% gross margin, 18.52% operating margin, and 12.57% net margin reflect a higher-value specialty-services model, while return on equity was 21.96% and return on assets was 7.23%. Revenue grew 9.7% year over year and earnings grew 3.3%; estimated next-year EPS of $9.4163 compares with trailing EPS of $7.41. The trade-off is valuation: core trailing and forward P/E ratios were 37.1619 and 29.6736, respectively, against EBITDA of $4.136 billion on revenue of $16.843 billion.

Recent momentum. Ecolab’s latest reported quarter delivered EPS of $2.09 versus an estimate of $2.08, a 0.5% beat. Its completed-quarter beat rate was 3/7, with several results matching estimates and one 0.5% miss in July 2025, so execution has been steady rather than consistently above expectations. Analyst sentiment included 6 Buys and 8 Holds with no Sell count, a 4.1852 consensus score, and an average target of $324.9524.

Pick #2Premium members only

Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →
Pick #1Premium members only

Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.

Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.

Get Full Access →

Methodology

This screen covers US-listed companies with market capitalizations above $500 million and identifiable exposure to water infrastructure. Eligible businesses include regulated water and wastewater utilities, manufacturers of pumps, valves, heaters, meters, tanks, and treatment equipment, as well as providers of filtration, specialty water chemistry, leak detection, monitoring, and related services. Companies were ordered first by the depth and directness of their water-infrastructure exposure, then by business fundamentals such as profitability, revenue and earnings growth, valuation, composite quality grade, analyst consensus, and recent earnings performance. The article is refreshed monthly using the latest available primary-source financial data and composite metrics; the presentation remains a countdown from #7 to #1.

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Don't trade alone.

Get market intelligence delivered daily.

Get Full Access →

Not ready to subscribe? ·

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌More stock lists

More to read

All articles
3 Identity Security Stocks Worth Watching Right Now — September 2026

3 Identity Security Stocks Worth Watching Right Now — September 2026

This three-stock countdown covers access management, identity governance, privileged access, authentication, and machine identities, featuring Okta and SailPoint.

Sep 24·8 min
Advanced Drainage Systems (WMS): Margin Expansion Drives Buy Case
WMS

Advanced Drainage Systems (WMS): Margin Expansion Drives Buy Case

Advanced Drainage Systems posted 21% revenue growth and 29% adjusted EBITDA growth in fiscal Q1 2027, with margin expansion reinforcing a constructive medium-term view. The stock still looks fairly valued near the report’s $170 estimate, but operating momentum supports a Buy rating.

Aug 31·21 min
Gene Therapy Stocks That Turn Science Into Sales: 7 Picks

Gene Therapy Stocks That Turn Science Into Sales: 7 Picks

A countdown of seven gene therapy stocks spans commercial treatments, gene-editing platforms, rare-disease specialists, and diversified pharmaceutical exposure.

Sep 22·13 min